Results 21 to 27 of about 33 (27)

Substances of plant origin and their potential application in treating Alzheimer’s disease

open access: yes, 2015
Alzheimer’s disease is the most common neurodegenerative condition in elderly people which is characterised by progressing dementia. Patients present weaker episodic memory, attention and orientation disorders as well as cognitive and language ...
Pypno, Damian, Zdrojewicz, Zygmunt
core  

The role of acetylocholinesterase inhibitors in the treatment of dementive syndromes

open access: yes, 2011
Postępujący lub rzadziej utrwalony deficyt funkcji poznawczych jest podstawowym objawem klinicznym otępień. Charakteryzuje się on upośledzeniem zwłaszcza pamięci, ale także innych funkcji poznawczych, takich jak zdolności językowe, apraksją, agnozją oraz
Papuć, Ewa
core  

Active and passive immunization strategies as treatments of Alzheimer’s disease

open access: yes, 2008
Currently available pharmacotherapeutics (cholinesterase inhibitors and memantin) for Alzheimer’s disease (AD) exert mainly symptomatic effect and doubtful, if any, disease-modifying activities.
Sobów, Tomasz
core  

Pharmacotherapy of cognitive dysfunctions in Alzheimer’s disease: current strategies and experimental therapies

open access: yes, 2013
Currently available methods of pharmacological treatment of cognitive dysfunction related to Alzheimer’s disease (AD) are based on augmentation of cholinergic neurotransmission (by inhibiting activity of cholinesterases) or modulation of glutamatergic ...
Sobów, Tomasz
core  
Some of the next articles are maybe not open access.

Related searches:

Memantyna w leczeniu zespołów otępiennych

Polski Przegląd Neurologiczny, 2014
openaire  

Home - About - Disclaimer - Privacy